Shares in contract medical services company IQnovate (NSX:IQN) start strong, but then pare some of their early gains, during the first day of public trading. [ + ]

A super-resolution imaging system that can produce real-time footage of living cells has been installed in the University of Technology Sydney. [ + ]

Compumedics (ASX:CMP) has picked up a deal to supply an EEG system to the Yale School of Medicine. [ + ]

IVD Australia has expressed disappointment that the Therapeutic Goods Administration's new blueprint on regulation of the promotion of therapeutic goods doesn't do enough to raise ethical standards in the industry. [ + ]

Drug discovery company Phylogica (ASX:PYC) has received its first milestone payment from a collaboration with Pfizer to discover novel peptide-based vaccines. [ + ]

Scientists in Canada have overcome a key research hurdle to developing regenerative treatments for diabetes and liver disease with a technique to produce medically useful amounts of endoderm cells from human pluripotent stem cells.

Registrations of interest are open now for three components of the Government's soon-to-be-released $1.2 billion Clean Technology Program. [ + ]

United Bioresearch Products has been appointed as the Australian distributor for the Biomedica range of ELISA kits and antibodies. [ + ]

A cabinet reshuffle has seen Greg Combet take over as Innovation Minister from Kim Carr, who has been demoted to the outer ministry. [ + ]

Professor Peter Høj, Vice Chancellor and President of the University of South Australia, has been appointed a part-time member to the CSIRO Board.

Dutch CMO DSM Biologics has signed a MoU with the Australian Institute for Bioengineering and Nanotechnology to open Australia’s largest biologics facility in Queensland. [ + ]

The needle-free vaccination technology by Vaxxas has won the overall award at the inaugural The Australian Innovation Challenge. [ + ]

A vaccine that slows the progression of Alzheimer’s disease and other types of dementia has been developed by researchers at the University of Sydney’s Brain and Mind Research Institute (BMRI).

CSL will contribute $2.5 million of immunoglobulin to an NIH-led trial to combat cytomegalovirus (CMV) in pregnant women to prevent congenital CMV in infants. [ + ]

The Australian Private Equity and Venture Capital Association welcomes the government's $100m funding to the Innovation Investment Fund but calls for continued policy commitment. [ + ]